IMPORTANT MESSAGE REGARDING COVID-19

Babies Born Addicted to Opioids Cost U.S. Over $500 Million per Year

Opioid Victims

In the year preceding the onset of the coronavirus pandemic of 2020, the opioid epidemic led the headlines. Studies were conducted, opioid lawsuits were filed, and new regulations aimed at holding drug manufacturers and prescribers responsible for the havoc the highly addictive drugs wreaked on millions were passed. Yet the stranglehold of addiction persists, albeit in the shadow of COVID-19.

As millions of Americans come out from under the coronavirus pandemic blanket with mass vaccinations and opening economies, the opioid epidemic is fast coming back to the fore with a focus on its most innocent victims.

The resumed interest has opioid attorneys working overtime filing opioid lawsuits for clients whose exposure to the drugs around and during pregnancy have led to their children being born with neonatal abstinence syndrome (NAS).

What is Neonatal Abstinence Syndrome?

The Journal of the American Medical Association (JAMA) defines NAS as “a withdrawal syndrome primarily occurring in infants with in-utero exposure to opioids.” It is a diagnosis that occurs “6.7 times per 1,000 live hospital births and costs the U.S. $572.7 million each year,” according to the Healthcare Cost and Utilization Project (HCUP) Kids’ Inpatient Database (KID), which studied a nationally representative sample of all pediatric discharges, as reported in JAMA. Medicaid-covered births account for 83.3 percent of the total cost ($477 million). Babies’ stay in the hospital can be 20.4 days or more with an average cost to families of $22,552.

The Project defined in-hospital births as “those with a primary/secondary diagnosis of live birth and no indication of birth outside the hospital or transfer from another hospital.”

While NAS can happen to any baby exposed to opioids in-utero, the highest incidence rates were among “American Indian/Alaska Native individuals (15.0 per 1,000) and non-Hispanic white people (10.5 per 1,000), the lowest income quartile (9.3 per 1,000), rural areas (10.6 per thousand), and the Northeast (9.5 per 1,000).” Medicaid-covered births had the highest NAS rates (12.3 per 1,000) with those without any kind of insurance just behind at 7.0 per 1,000.

What the Research Shows

The U.S. Department of Health and Human Services reports that 10.1 million people misused prescription opioids in the past year. More than 70 thousand died from overdose, and 1.6 million people misused prescription pain relievers for the first time.

Women who experience severe pain before or during their pregnancies are still commonly being treated with opioids, most often with codeine and oxycodone, according to the Centers for Disease Control (CDC). This is a problem, because “opioid use during pregnancy can affect women and their babies.”

The National Birth Defects Prevention Study conducted from 1997 through 2005, which studied just over 19,000 maternal cases, supports that finding as it showed there is an “association between early pregnancy maternal opioid analgesic treatment and certain birth defects.”

These findings lend support to parents with NAS-affected babies who wish to seek claims against opioid manufacturers and prescribers.

Most Common Opioid-Related Birth Defects

The latest Centers for Disease Control (CDC) study, “Maternal Treatment with Opioid Analgesics and Risk for Birth Defects,” published in the American Journal of Obstetrics and Gynecology, reveals “codeine and hydrocodone were the most frequently prescribed medications, representing 69 percent of all reported opioid analgesics used.” The reasons for a prescribed opioid regimen during pregnancy include chronic diseases, infections, injuries, and surgical procedures.

Treatment with opioid analgesic, according to the study, was linked with congenital heart defects such as:

  • Atrial septal defect
  • Atrioventricular septal defect
  • Conoventricular septal defect
  • Hypoplastic left heart syndrome
  • Pulmonary valve stenosis
  • Tetralogy of Fallot

The study says the “findings related to congenital heart defects were consistent with findings of previous studies showing links between the use of codeine during the first trimester and the occurrence of some heart defects.”

Other common birth defects include:

  • Gastroschisis (a defect of the abdominal wall)
  • Glaucoma (an eye defect)
  • Hydrocephaly (build-up of fluid in the brain)
  • Spina bifida (a type of neural tube defect)

How We Help Opioid Victims Who Suffered Birth Defects

Contact us to seek justice with the help of our experienced opioid attorneys. We’ve battled corporate giants on behalf of individuals like you for 20 years. Our Dallas, Texas, opioid law firm represents families dealing with opioid-related birth defects. If you have a child with birth defects caused by exposure to opioids during the first trimester of pregnancy, we can help.

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880